Microcap Ledger Quanome Technologies, Inc. $QNME
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Arrangement of Transportation of Freight & Cargo
- Headquarters
- Itasca, IL
- Fiscal year end
- June 30
- Shares outstanding
- 34,427,559 [10-K 2026-09-25]
What the company doesAI summary of filing
Quanome Technologies, Inc. operates three principal business areas. Its established, revenue-generating pharmaceutical distribution operations are conducted through subsidiary Hupan Pharmaceutical in China, where it distributes infusion products, foods for special medical purposes, and specialty pharmaceuticals to hospitals, distributors and healthcare providers. The company recently initiated quantum-related and advanced technology activities through subsidiary Quantum Nexus, which remain in the development and evaluation stage with no revenue generated as of the report date. Additionally, beginning in September 2026, the company commenced artificial intelligence compute capacity and managed inference services through subsidiary XDT Infrastructure I, LLC, which remains in preliminary stages with no executed customer contracts or revenue as of the report date. [10-K 2026-09-25]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| FY ended Jun 2026 | $5.85M | −$9.48M | −$3.18M | $670.3K | [10-K 2026-09-25] |
| FY ended Jun 2025 | $2.76M | −$5.25M | −$2.66M | $4.81M | [10-K 2026-09-25] |
- Quarterly cash burn
- −$795.9K
- Cash runway Estimate
- ~2.5 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-14 | 7,500,000 | [10-Q 2024-11-14] |
| 2025-02-14 | 7,500,000 | [10-Q 2025-02-14] |
| 2025-03-31 | 7,500,000 | [10-Q 2025-05-15] |
| 2025-10-10 | 17,427,559 | [10-K 2025-10-14] |
| 2025-11-19 | 17,427,559 | [10-Q 2025-11-19] |
| 2025-12-31 | 34,427,559 | [10-Q 2026-02-19] |
| 2026-03-31 | 34,427,559 | [10-Q 2026-05-19] |
| 2026-09-22 | 34,427,559 | [10-K 2026-09-25] |
- Shelf registration
- S-3 filed 2026-07-08; no effectiveness notice found in EDGAR [S-3 2026-07-08]
Listing status
Current status: 4 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-07-10. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-07-10 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-07-10] |
| 2026-01-09 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-01-09] |
| 2025-08-01 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-08-01] |
| 2025-02-27 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2025-02-27] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-10-09 | 8-K | Regulation FD disclosure |
| 2026-10-05 | 8-K | Material agreement entered |
| 2026-10-01 | 8-K | Material agreement entered; New financial obligation; Regulation FD disclosure |
| 2026-10-01 | S-3/A | Registration statement |
| 2026-09-25 | 10-K | Annual report |
| 2026-09-25 | 8-K | Regulation FD disclosure |
| 2026-09-23 | 8-K | Regulation FD disclosure |
| 2026-09-21 | 8-K | Director or officer change |
| 2026-09-21 | 8-K | Material agreement entered |
| 2026-09-02 | S-3/A | Registration statement |
| 2026-08-20 | 8-K | Regulation FD disclosure |
| 2026-08-05 | 8-K | Regulation FD disclosure |
Alerts for $QNME
Email me when Quanome Technologies, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.